Hudson Bay Capital Management LP Sorrento Therapeutics, Inc. Transaction History

Hudson Bay Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.0 - $4.9 $175,518 - $430,019	-87,759 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $408,079 - $634,497	87,759 New	87,759 $408,000
Q3 2020 Nov 12, 2020	SELL	$6.17 - $18.82 $1.11 Million - $3.39 Million	-180,000 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.73 - $6.76 $311,400 - $1.22 Million	180,000 New	180,000 $1.13 Million
Q3 2019 Nov 13, 2019	SELL	$2.05 - $2.69 $1.36 Million - $1.78 Million	-662,059 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.67 - $4.38 $1.77 Million - $2.9 Million	662,059 New	662,059 $1.77 Million

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.